Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.28 | 7e-07 |
mRNA | PSMB4 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-05 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-05 |
mRNA | C1D | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-05 |
mRNA | OTUD7B | CTRPv2 | pan-cancer | AAC | -0.22 | 0.0003 |
mRNA | MRPS21 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-05 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-05 |
mRNA | PRELID1 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-05 |
mRNA | HNF4A | CTRPv2 | pan-cancer | AAC | -0.21 | 0.002 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-05 |